[1] 鲍娟, 唐丽玲, 周全,等. 重症肌无力患者胸腺切除术后危象的护理[J].护士进修杂志, 2016, 31(5):436-438. [2] 范文君, 林宏, 常婷,等. 胸腺切除术治疗重症肌无力的疗效及其影响因素分析[J].中国神经免疫学和神经病学杂志, 2016, 23(1):1-4. [3] Kagawa T, Watanabe M, Inoue N,et al. Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease[J].Endocr J,2016, 63(4):375-378. [4] Keijzers M, Damoiseaux J, Vigneron A, et al. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy[J].Autoimmunity,2015, 48(8):552-555. [5] 陈群.胸腺切除术后并发重症肌无力危象的救治经验总结[J].中国全科医学, 2016, 19(23):2833-2836. [6] Elnasr MMA, El-Guindy DM, Al-Malt AM, et al. Thymectomy in non thymomatous myasthenia gravis: impact of pathology on outcome and role of survivin in pathogenesis[J]. Journal of the Egyptian Society of Cardio-Thoracic Surgery,2016, 24(4):26-31. [7] 杨春艳, 宋宇龙, 王晖. 重症肌无力患者胸腺切除术后需要呼吸机支持的影响因素分析[J].解放军预防医学杂志, 2017, 35(8):1-4. [8] Hu B, Simon-Keller K, Küffer S, et al. Myf5 and myogenin in the development of thymic myoid cells-implications for a murine in vivo model of myasthenia gravis[J].Exp Neurol,2016, 277:76-85.
2019, Vol. 36 
